J C JR WATTS, a director at $DDS, sold 750 shares of the company on 10-16-2025 for an estimated $445,950. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.8% of their shares of this class of stock. Following this trade, they now own 10,250 shares of this class of $DDS stock.
$DDS Insider Trading Activity
$DDS insiders have traded $DDS stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $DDS stock by insiders over the last 6 months:
- J C JR WATTS sold 750 shares for an estimated $445,950
- CHRIS B. JOHNSON (SENIOR VICE PRESIDENT) sold 400 shares for an estimated $246,800
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DDS Hedge Fund Activity
We have seen 132 institutional investors add shares of $DDS stock to their portfolio, and 130 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NEW VERNON CAPITAL HOLDINGS II LLC removed 186,228 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $77,811,645
- NEWPORT TRUST COMPANY, LLC removed 100,385 shares (-2.1%) from their portfolio in Q2 2025, for an estimated $41,943,864
- WEDGE CAPITAL MANAGEMENT L L P/NC added 62,608 shares (+756.9%) to their portfolio in Q3 2025, for an estimated $38,471,363
- BLACKROCK, INC. added 58,407 shares (+34.7%) to their portfolio in Q2 2025, for an estimated $24,404,196
- VOLORIDGE INVESTMENT MANAGEMENT, LLC added 58,328 shares (+456.2%) to their portfolio in Q2 2025, for an estimated $24,371,188
- UBS GROUP AG added 54,788 shares (+403.0%) to their portfolio in Q2 2025, for an estimated $22,892,070
- MILLENNIUM MANAGEMENT LLC removed 42,877 shares (-95.9%) from their portfolio in Q2 2025, for an estimated $17,915,296
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DDS Analyst Ratings
Wall Street analysts have issued reports on $DDS in the last several months. We have seen 0 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Sell" rating on 08/15/2025
- JP Morgan issued a "Underweight" rating on 07/28/2025
To track analyst ratings and price targets for $DDS, check out Quiver Quantitative's $DDS forecast page.
$DDS Price Targets
Multiple analysts have issued price targets for $DDS recently. We have seen 3 analysts offer price targets for $DDS in the last 6 months, with a median target of $458.0.
Here are some recent targets:
- Dana Telsey from Telsey Advisory Group set a target price of $550.0 on 08/15/2025
- Mauricio Serna from UBS set a target price of $175.0 on 08/15/2025
- Matthew Boss from JP Morgan set a target price of $458.0 on 07/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
